Literature DB >> 29262732

Chk1 modulates the interaction between myosin phosphatase targeting protein 1 (MYPT1) and protein phosphatase 1cβ (PP1cβ).

Xiaomei Hu1, Zhe Li1, Yuehe Ding2, Qizhi Geng1, Zhikai Xiahou1, Huanwei Ru1, Meng-Qiu Dong2, Xingzhi Xu1,3, Jing Li1.   

Abstract

Polo-like kinase 1 (Plk1) is an instrumental kinase that modulates many aspects of the cell cycle. Previous investigations have indicated that Plk1 is a target of the DNA damage response, and Plk1 inhibition is dependent on ATM/ATR and Chk1. But the exact mechanism remains elusive. In a proteomic screen to identify Chk1-interacting proteins, we found that myosin phosphatase targeting protein 1 (MYPT1) was present in the immunocomplex. MYPT1 is phosphorylated by CDK1, thus recruiting protein phosphatase 1β (PP1cβ) to dephosphorylate and inactivate Plk1. Here we identified that Chk1 directly interacts with MYPT1 and preferentially phosphorylates MYPT1 at Ser20, which is essential for MYPT1-PP1cβ interaction and subsequent Plk1 dephosphorylation. Phosphorylation of Ser20 is abolished during mitotic damage when Chk1 is inhibited. The degradation of MYPT1 is also regulated by Chk1 phosphorylation. Our results thus unveil the underlying machinery that attenuates Plk1 activity during mitotic damage through Chk1-induced phosphorylation of MYPT1.

Entities:  

Keywords:  Cell cycle; DNA damage; MYPT1; PP1cβ; Plk1; mitosis

Mesh:

Substances:

Year:  2018        PMID: 29262732      PMCID: PMC5927650          DOI: 10.1080/15384101.2017.1418235

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

Review 1.  The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

Authors:  Joanne Smith; Lye Mun Tho; Naihan Xu; David A Gillespie
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

2.  Chk1 is required for spindle checkpoint function.

Authors:  George Zachos; Elizabeth J Black; Mark Walker; Mary T Scott; Paola Vagnarelli; William C Earnshaw; David A F Gillespie
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

3.  Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression.

Authors:  David Kachaner; Josina Filipe; Emmanuel Laplantine; Angela Bauch; Keiryn L Bennett; Giulio Superti-Furga; Alain Israël; Robert Weil
Journal:  Mol Cell       Date:  2012-02-24       Impact factor: 17.970

Review 4.  Unleashing Chk1 in cancer therapy.

Authors:  Laura Carrassa; Giovanna Damia
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

5.  Bora and Aurora-A continue to activate Plk1 in mitosis.

Authors:  Wytse Bruinsma; Libor Macurek; Raimundo Freire; Arne Lindqvist; René H Medema
Journal:  J Cell Sci       Date:  2013-12-11       Impact factor: 5.285

6.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

7.  GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers.

Authors:  Tiebang Kang; Yongkun Wei; Yuchi Honaker; Hiroshi Yamaguchi; Ettore Appella; Mien-Chie Hung; Helen Piwnica-Worms
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

8.  Plk1 phosphorylation of Numb leads to impaired DNA damage response.

Authors:  C Shao; S-J Chien; E Farah; Z Li; N Ahmad; X Liu
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

9.  Checkpoint kinase 1-induced phosphorylation of O-linked β-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis.

Authors:  Zhe Li; Xueyan Li; Shanshan Nai; Qizhi Geng; Ji Liao; Xingzhi Xu; Jing Li
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

10.  A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response.

Authors:  Scott C Smith; Aleksandra V Petrova; Matthew Z Madden; Hongyan Wang; Yunfeng Pan; Matthew D Warren; Claire W Hardy; Dong Liang; Elaine A Liu; M Hope Robinson; Soumon Rudra; Jie Wang; Shahrzad Ehdaivand; Mylin A Torres; Ya Wang; David S Yu
Journal:  Nucleic Acids Res       Date:  2014-09-12       Impact factor: 16.971

View more
  6 in total

1.  Chk2-dependent phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) regulates centrosome maturation.

Authors:  Shanshan Nai; Yingxin Shi; Huanwei Ru; Yuehe Ding; Qizhi Geng; Zhe Li; Meng-Qiu Dong; Xingzhi Xu; Jing Li
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

2.  Epigallocatechine-3-gallate Inhibits the Adipogenesis of Human Mesenchymal Stem Cells via the Regulation of Protein Phosphatase-2A and Myosin Phosphatase.

Authors:  Bálint Bécsi; Zoltán Kónya; Anita Boratkó; Katalin Kovács; Ferenc Erdődi
Journal:  Cells       Date:  2022-05-20       Impact factor: 7.666

3.  O-GlcNAcylation of myosin phosphatase targeting subunit 1 (MYPT1) dictates timely disjunction of centrosomes.

Authors:  Caifei Liu; Yingxin Shi; Jie Li; Xuewen Liu; Zhikai Xiahou; Zhongping Tan; Xing Chen; Jing Li
Journal:  J Biol Chem       Date:  2020-04-15       Impact factor: 5.157

Review 4.  Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.

Authors:  Helen E Collins; John C Chatham
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-31       Impact factor: 5.187

5.  miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells.

Authors:  Xuemei Li; Shujun Zhao; Yan Ye; Baoli Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-04       Impact factor: 3.168

Review 6.  DNA replication and mitotic entry: A brake model for cell cycle progression.

Authors:  Bennie Lemmens; Arne Lindqvist
Journal:  J Cell Biol       Date:  2019-11-11       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.